Wire Stories

AnHeart and Innovent Announce Interim Data from Phase ? Trial (TRUST) of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting

In the crizotinib treatment-naïve patient group (n=21), the confirmed objective response rate (ORR) was 90.5%…

AnHeart and Innovent Announce Interim Data from Phase ? Trial (TRUST) of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting

In the crizotinib treatment-naïve patient group (n=21), the confirmed objective response rate (ORR) was 90.5%…

The World Economic Forum Welcomes Western Digital to Prestigious Global Lighthouse Network

Western Digital’s smart facilities in Malaysia and Thailand are the first Lighthouses to be accepted…

D&D Pharmatech Announces Agreement with Salubris Pharmaceuticals for Licensing and Development of DD01 in China

D&D will receive an upfront payment of $4 million and is eligible to receive additional…

Ingram Micro Commerce & Lifecycle Services Executive Receives Supply Chain Award

AUCKLAND, New Zealand--(BUSINESS WIRE)--#3pl--Ingram Micro Commerce & Lifecycle Services today announced that Lisa Flynn, director,…

Rendanheyi Now a Frequently Mentioned Term in Business Globally

QINGDAO, China--(BUSINESS WIRE)--From the Business Roundtable in the US redefining the purpose of a corporation…

Vecow and Blaize Team to Deliver Leading Workstation-grade Edge AI Computing Solution

Vecow ECX-2400 AI Computing System targets demanding industrial applications with higher system reliability, lower power…

Hong Kong Tourism Board and CJ ENM Join Forces to Hype up Tourism Interests with K-pop Culture

HONG KONG--(BUSINESS WIRE)--#DiscoverHongKong--The Hong Kong Tourism Board (HKTB) signed a three-year deal with CJ ENM,…

The Technological Spokesperson for Chinese Art, Tyfon Culture

SUZHOU, China--(BUSINESS WIRE)--The art of Chinese painting that the world is familiar with, is mostly…

Japan’s MHLW Approves PADCEV® (enfortumab vedotin) for Advanced Urothelial Cancer

- Enfortumab vedotin is the first and only antibody-drug conjugate (ADC) approved in Japan for…